Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Cell Death and Differentiation
|
December 13, 2005
The p53 family inhibitor DeltaNp73 interferes with multiple developmental programs
N Hüttinger-Kirchhof, H Cam, H Griesmann, et al.
Molecular and Cellular Neurosciences
|
July 20, 2001
Identification of the full-length huntingtin- interacting protein p231HBP/HYPB as a DNA-binding factor
S Rega, T Stiewe, D I Chang, et al.
Journal of the National Cancer Institute
|
March 22, 2001
Large nontransplanted hepatocellular carcinoma in woodchucks: treatment with adenovirus-mediated delivery of interleukin 12/B7.1 genes
B M Pützer, T Stiewe, F Rödicker, et al.
Cell Death & Disease
|
December 16, 2011
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells
M Michaelis, F Rothweiler, S Barth, et al.
Leukemia
|
May 16, 2015
NFATc1 as a therapeutic target in FLT3-ITD-positive AML
S K Metzelder, C Michel, M von Bonin, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Cell Death and Differentiation
|
December 13, 2005
The p53 family inhibitor DeltaNp73 interferes with multiple developmental programs
N Hüttinger-Kirchhof, H Cam, H Griesmann, et al.
Molecular and Cellular Neurosciences
|
July 20, 2001
Identification of the full-length huntingtin- interacting protein p231HBP/HYPB as a DNA-binding factor
S Rega, T Stiewe, D I Chang, et al.
Journal of the National Cancer Institute
|
March 22, 2001
Large nontransplanted hepatocellular carcinoma in woodchucks: treatment with adenovirus-mediated delivery of interleukin 12/B7.1 genes
B M Pützer, T Stiewe, F Rödicker, et al.
Cell Death & Disease
|
December 16, 2011
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells
M Michaelis, F Rothweiler, S Barth, et al.
Leukemia
|
May 16, 2015
NFATc1 as a therapeutic target in FLT3-ITD-positive AML
S K Metzelder, C Michel, M von Bonin, et al.
Page
of 2